More than 90% of PAP patients have idiopathic PAP (iPAP), a primary acquired disorder without familial predisposition in which GM-CSF neutralizing auto-antibodies are present [4, 7]. The gene discussed is CSF2; the disease is autoimmune pulmonary alveolar proteinosis.